Eiskjaer H, Nielsen C B, Pedersen E B
Department of Medicine and Nephrology C. Skejby Hospital, Aarhus, Denmark.
J Intern Med. 1994 Dec;236(6):665-74. doi: 10.1111/j.1365-2796.1994.tb00860.x.
To examine whether the effect of atrial natriuretic peptide (ANP) on renal glomerular and tubular segmental handling of sodium in patients with essential hypertension is pressure dependent.
Part 1. The renal effects of a low-dose continuous infusion (10 ng kg-1 min-1) with ANP for 1 h were compared in 10 untreated essential hypertensives (EH) and 13 normotensive control subjects (CS). Part 2. The hypertensives were studied on another day with ANP infusion during preceding acute BP reduction with sodium nitroprusside infusion (NP). The results were compared with those obtained during infusion with ANP+placebo (Part 1).
Lithium clearance was used to estimate the proximal tubular reabsorption of sodium.
Part 1. Atrial natriuretic peptide caused an exaggerated increase in urinary sodium excretion (+102 vs. +38%: P < 0.05), fractional excretion of sodium (+80 vs. +37%: P < 0.05), and urinary output (+56 vs. +8.3%; P < 0.05) in EH compared with CS. Glomerular filtration rate and filtration fraction increased to the same degree in both groups. Absolute lithium clearance (CLi) increased and FELi tended to increase (P = 0.061) in EH, but these were unchanged in CS. The increase in plasma cyclic guanosine 5'-phosphate (cGMP) and urinary excretion of cGMP and the decrease in plasma aldosterone during ANP infusion were the same in the two groups. Part 2. During NP infusion the natriuresis caused by ANP in EH was reduced (+51 vs. +99%; P < 0.05). The relative changes in GFR, CLi, and FELi during ANP infusion were not affected by the preceding BP reduction with NP. Mean arterial pressure was reduced from 122 to 101 mmHg during NP infusion. The relative increase in sodium excretion in EH was significantly correlated to mean arterial pressure.
Low-dose ANP infusion causes an exaggerated natriuresis in untreated essential hypertensives due to a more pronounced reduction in tubular reabsorption. After BP reduction, the natriuresis induced by ANP in essential hypertensives is decreased, probably due to a less pronounced reduction in tubular reabsorption beyond the proximal tubules. We suggest that the enhanced natriuretic response to ANP in EH in secondary in some degree to the elevated systemic pressure.
研究原发性高血压患者中,心房利钠肽(ANP)对肾肾小球和肾小管节段性钠处理的影响是否依赖于血压。
第一部分。比较10例未经治疗的原发性高血压患者(EH)和13例血压正常的对照者(CS)在静脉持续输注低剂量ANP(10 ng·kg⁻¹·min⁻¹)1小时后的肾脏效应。第二部分。在另一天,对高血压患者先静脉输注硝普钠(NP)进行急性降压,然后输注ANP,并将结果与输注ANP + 安慰剂时(第一部分)的结果进行比较。
用锂清除率评估近端肾小管钠重吸收。
第一部分。与CS相比,ANP使EH患者尿钠排泄显著增加(分别为 +102% 对 +38%;P < 0.05)、钠分数排泄增加(分别为 +80% 对 +37%;P < 0.05)和尿量增加(分别为 +56% 对 +8.3%;P < 0.05)。两组的肾小球滤过率和滤过分数升高程度相同。EH患者的绝对锂清除率(CLi)增加,锂排泄分数(FELi)有增加趋势(P = 0.061),而CS患者无变化。两组在输注ANP期间血浆环磷酸鸟苷(cGMP)增加、尿cGMP排泄增加以及血浆醛固酮降低的情况相同。第二部分。在输注NP期间,EH患者中ANP引起的利钠作用减弱(分别为 +51% 对 +99%;P < 0.05)。在输注ANP期间,GFR、CLi和FELi的相对变化不受之前NP降压的影响。在输注NP期间,平均动脉压从122 mmHg降至101 mmHg。EH患者钠排泄的相对增加与平均动脉压显著相关。
低剂量输注ANP可使未经治疗的原发性高血压患者产生过度利钠作用,这是由于肾小管重吸收更显著降低所致。血压降低后,原发性高血压患者中ANP诱导的利钠作用减弱,可能是由于近端小管以外的肾小管重吸收降低不那么明显。我们认为,EH患者对ANP的利钠反应增强在一定程度上继发于全身血压升高。